This segment provides direct-to-consumer genetic testing services, offering customers insights into their ancestry, health predispositions, and carrier status for various genetic conditions. Research and development activities include the continuous improvement of genotyping and analysis technologies, as well as the development of new reports and features. The segment utilizes advanced genotyping and bioinformatics methodologies to analyze saliva samples and generate personalized reports. It covers a wide range of applications, including ancestry tracing, health risk assessment, and pharmacogenomics. The patient impact is significant, as individuals gain a deeper understanding of their genetic makeup, enabling them to make informed decisions about their health and lifestyle. Market positioning is strong due to the company's large consumer database and brand recognition. Future opportunities include expanding the range of health reports and integrating with other healthcare services. Regulatory aspects involve compliance with FDA regulations and data privacy standards. Partnerships include collaborations with pharmaceutical companies for research and drug development.

The Therapeutics segment focuses on the discovery and development of novel therapies, leveraging genetic insights to identify and validate drug targets. Research and development activities include preclinical studies, clinical trials, and the development of new drug candidates. The segment utilizes advanced genomic analysis, target validation, and drug development methodologies. It primarily focuses on therapeutic areas such as oncology, respiratory, and cardiovascular diseases. The patient impact is substantial, as the segment aims to develop innovative treatments for serious diseases. Market positioning is based on the company's unique genetic data and its collaborations with pharmaceutical companies. Future opportunities include expanding the pipeline of drug candidates and securing regulatory approvals. Regulatory aspects involve navigating the complex process of clinical trials and FDA approval. Partnerships include collaborations with GlaxoSmithKline and Regeneron for drug development and commercialization.